The legacy status of Viagra, and this parent firm copyright, presents a challenging question for investors . While earnings initially soared , the impending patent expiry and growing generic competition https://joycekjpv368413.blogerus.com/63503851/the-blue-pill-and-the-pharmaceutical-industry-a-risky-investment